baber/WOPTO huggingface dataset:
Patent JP-H09512458-A (JP)
Title: 体内人工器官及びステントの配置
IPC: A61F2/06
Filed: 1995-04-18
Abstract: (57)【要約】
本発明は身体の通路の管腔内に体内人工器官（４）を移植する方法及び装置に関する。選択された身体通路を管内移送するための小径の外径を有する管状の細長い体内人工器官（４）は外側に作用する力を加えることで膨張した径に漸次的に永久変形することができる。体内人工器官（４）は、該体内人工器官の軸線方向寸法より短い軸線方向寸法を有した膨張自在の半径方向に膨張可能なバルーン（３）を有するカテーテル（２）上に設けられる。細長い体内人工器官（４）は非膨張状態で身体通路内の所望の位置に挿入され、カテーテルを該カテーテルの膨張自在の部分が体内人工器官（４）の第１部分の内側に整合するように位置決めした状態で、該カテーテルの膨張自在の部分を膨張させて、体内人工器官（４）の第１部分を膨張した径に変形させる。カテーテル（２）の膨張自在の部分（３）は次いで萎まされて、体内人工器官の非膨張部分と整合するまで軸線方向に移動され、カテーテル（２）の膨張自在の部分（３）の膨張が細長い体内人工器官（４）が所望の長さに亙って膨張し且つ該体内人工器官が管腔内で永久に配置されるまで繰り返される。
Patent JP-H11502805-A (JP)
IPC: H01T23/00
Filed: 1996-03-18
Abstract: The invention relates to a process and device for generating gaseous oxygen anionic radicals under atmospheric pressure with a carbon fibre ionisation electrode. The aim of the invention is to provide a process and device as described which prevent any damaging contamination by health-threatening by-products of the ionisation process in the ionisation of air or medical oxygen. With regard to the process, this is attained in that uncharged by-products of the ionisation process, like nitric oxide and ozone, are separated by suction from the oxygen anionic radicals generated. In an advantageous embodiment an annular counter-electrode (7) is used which affects the whole region of the ionisation electrode (4) and permits the production of an electric field with defined geometry and voltage. In the device of the invention the aforementioned problem is correspondingly solved in that there is a suction device (11, 12, 13) by means of which the uncharged by-products of the ionisation process can be separated from the oxygen anionic radicals produced.
Patent JP-2000504805-A (JP)
IPC: B03C3/70
Filed: 1997-02-10
Abstract: The invention relates to a device for the cleaning of exhaust gases from internal combustion engines, in particular a diesel exhaust soot filter. Said device has a discharge electrode (8), a counterelectrode (28) opposite thereto for electrical charging of the exhaust gas components, a ceramic structure (1) with a circular cross-section and ducts (20) extending therethrough in the direction of flow, and an internal electrode (5) at high voltage. This electrode is arranged on the inner cylinder wall (21) of the ceramic structure (1) and creates an electrical field at right angles to the ducts (20) passing through said ceramic structure. The soot particles are deposited and oxidised on the walls of the ducts (20), and a separation is provided to prevent flow through the hollow internal space (22) of the ceramic structure (1). To prevent the formation of conductive soot bridges between high-voltage-conducting components and earth the separation of the hollow internal space (22) of the ceramic structure (1) is an electrical insulator, preferably a ceramic stopper (4), arranged at the inlet side of the gas stream.
Patent JP-H11505595-A (JP)
Title: 結合されたバルブ構成部材から成るバルブ及びこのようなバルブを具える燃料噴射システム
IPC: F02M69/32
Filed: 1997-02-07
Abstract: (57)【要約】
バルブ（４１）にインレット（４３）と第１アウトレット（４９）と第２アウトレット（５５）とを設ける。バルブ（４１）の第１バルブ構成部材（５７）が第１アウトレット（４９）のバルブシート（５９）と協働し、バルブ（４１）の第２バルブ構成部材（６１）が第２アウトレット（５５）のバルブシート（６３）と協働する。第１及び第２バルブ構成部材（５７、６１）は共通のドライングシャフト（６７）上に設けられ、このドライビングシャフトは第１アウトレット（４９）を通って流れる空気と第２アウトレット（５５）を通って流れる空気とを調整する電気作動装置（６９）により移動可能である。第１及び第２バルブ構成部材（５７、６１）は単一の集積バルブ構成部材（６５）に結合され、この集積バルブ構成部材は第１アウトレット（４９）のバルブシート（５９）と第２アウトレット（５５）のバルブシート（６３）の両方と協働する。バルブ（４１）の簡単且つ小型の構造はこのようにして得られる。バルブ（４１）は内燃エンジン（１）の空気援助燃料噴射システム（３）に使用され、このバルブ内ではバルブ（４１）の第１アウトレット（４９）がエンジン（１）のスロットルバルブ（２９）のバイパス（５１）に連結され、バルブ（４１）の第２アウトレット（５５）が燃料噴射システム（３）の気体援助燃料噴射装置（３１）に連結される。このようにして、燃料噴射装置（３１）により噴射された燃料の細分化とエンジン（１）のアイドリング速度が単一のバルブ（４１）により制御される。
Patent JP-H11512780-A (JP)
Title: 立体安定化非水性分散物、およびそれに基づいたコーティング組成物
IPC: C08G59/06
Filed: 1997-02-21
Abstract: (57)【要約】
本発明は、以下のa)およびb)を含むコーティング材料に関する：a)分散安定剤の存在下、有機溶媒中で、平均で１分子当たり少なくとも２つのエポキシ基を有する少なくとも１つのエポキシ樹脂(A)と、式HOROH(I)(ここで、Rは式-Ph-D-Ph-(II)の基であり、この-Ph-はフェニレン基およびDはメチレンまたはプロピレン基)の少なくとも１つのジオール(B)と、必要であれば、エポキシ基またはヒドロキシル基と反応する基を含むさらなる試薬(C)との反応によって生成される立体安定化非水性分散物、ならびに；b)少なくとも１つの架橋剤および、必要であれば、溶媒、顔料、フィラーならびに他の補助剤および添加物。該ジオール(I)は、イソプレンまたはポリイソプレンから誘導される化合物を含む安定剤によって立体安定化された非水性分散物の形態で存在する。
Patent JP-H11504035-A (JP)
Title: 糖により安定化されたガラス相の組成物
IPC: A61K47/26
Filed: 1996-04-26
Abstract: (57)【要約】
非晶質形態の水溶性または水膨潤性物質を含有する非晶質過冷却ガラス相を有する組成物において、結晶質水和物として存在することの可能な糖が、該非晶質相をそれからの結晶化により脱水してそれにより残留非晶質相のガラス転移温度を高めるための薬剤として用いられる。
Patent JP-2002506514-A (JP)
Title: バッテリゲージ
IPC: G01R31/36
Filed: 1997-01-23
Abstract: (57)【要約】
本発明は、バッテリから得られる電圧だけでなくバッテリから流れる電流量もモニタすることによって、バッテリの残り時間量を見積もりする。バッテリの電圧および電流の流出を定期的にサンプリングすることによりバッテリを正確にモニタすることが可能であることが分かった。サンプリング方法は、バッテリ電圧のサンプリングと電流の流出のサンプリングとの間で代替的に行う。対コスト効果が高いサンプリングを行うことが可能な電気回路が提供される。次にバッテリ電力の残り時間量を決定する方法がマイクロプロセッサによってサンプリング信号に対して適用される。好適な実施態様では、バッテリの残り時間の図形表示が提供される。
Patent JP-2000510460-A (JP)
IPC: A61K33/243
Filed: 1997-04-25
Abstract: A method for treating a tumor includes a first treatment procedure using a conventional cancer treatment technique, and a second treatment procedure which includes administering an effective amount of squalamine. The first treatment procedure may be a treatment with one or more conventional cytotoxic chemical compounds. As examples, the cytotoxic chemical compound may be a nitrosourea (such as BCNU), cyclophosphamide, adriamycin, 5-fluorouracil, paclitaxel and its derivatives, cisplatin or other platinum containing cancer treating agents. The cytotoxic chemical compound and the squalamine may be administered by any suitable route. The first treatment procedure may take place prior to the second treatment procedure, after the second treatment procedure, or the two treatment procedures may take place simultaneously. In one example, the first treatment procedure (e.g., a one time intravenous dosage of BCNU) is completed before the second treatment procedure with squalamine begins. As an alternative, the first treatment procedure may be a conventional radiation treatment regimen.
Patent JP-2001519900-A (JP)
IPC: C12Q1/68
Filed: 1998-03-18
Abstract: The present invention pertains to a method for determination of the significance of a histologically detected premalignant lesion as a risk for intestinal type gastric cancer or carcinoma in situ, comprising detecting from a patient sample comprising gastric mucosa cellsa) cyclooxygenase-2 Cox-2) mRNA expression, orb) Cox-2 protein;wherein overexpression of Cox-2 is indicative of an increased risk for intestinal type gastric cancer.
Patent JP-2000510166-A (JP)
Title: １―アルキル―４―（２―クロロ―３―アルコキシ―４―アルキルスルホニルベンゾイル）―５―ヒドロキシピラゾール及び関連化合物の製造法
IPC: C07C317/14
Filed: 1998-03-24
Abstract: (57)【要約】
除草性１−アルキル−４−（２−クロロ−３−アルコキシ−４−アルキルスルホニルベンゾイル）−５−ヒドロキシピラゾール化合物ならびに１−ハロ−２−クロロ−３−アルコキシ−４−アルキルスルホニルベンゼン化合物及び２−クロロ−３−アルコキシ−４−アルキルスルホニル安息香酸化合物を、対応する３−クロロ化合物とアルカリ金属アルコキシド化合物の反応により高収率で製造した。１−ハロ−２−クロロ−３−アルコキシ−４−アルキルスルホニルベンゼン及び１−ハロ−２，３−ジクロロ−４−アルキルスルホニルベンゼン化合物をパラジウムＩＩ塩：トリヒドロカルビルホスフィン錯体型触媒の存在下における一酸化炭素及びそれぞれ水、アルコール又は１−アルキル−５−ヒドロキシピラゾール化合物との反応により、１−ハロ置換基の代わりにヒドロキシカルボニル、アルコキシカルボニル又は１−アルキル−５−ヒドロキシピラゾール−４−カルボニル置換基を有する化合物に変換した。
Patent JP-2001517950-A (JP)
IPC: A23L33/15
Filed: 1998-03-30
Abstract: A nutritional formulation containing an effective amount of Lacto-N-neoTetraose to simulate the growth and/or metabolic activity of Bifidobacterium is provided. A process of inhibiting bacterial infections caused by Bacteroides, Clostridium, and E. coli including the step of feeding the nutritional composition to a subject is also provided.
Patent JP-2000511348-A (JP)
Title: 制御可能なインダクタ
IPC: H01F29/14
Filed: 1997-05-16
Abstract: (57)【要約】
制御可能なインダクタは、少なくとも、筒状コア３と、該コアを囲繞するメイン巻線１と、コアを実質的に軸線方向に通っている制御巻線４とを有している。該インダクタは、高い透磁性を有している材料のヨーク１９も有しており、該ヨーク１９はコアとメイン巻線との外側を延在するよう配備されているとともに、コアとともに、閉ループを形成するよう配備されており、該閉ループは、前記メイン巻線における電流によりコア内に発生されるメイン磁束のための多くとも小さいエアギャップを有しており、また、前記閉ループはコアに対して実質上軸線方向に延在している。制御巻線は、コアを通って実質的に軸線方向に延在している優れた電導性を有する材料の第１の板を有している。
Patent JP-2001524976-A (JP)
Title: 殺藻剤
IPC: A23L7/109
Filed: 1998-05-04
Abstract: (57)【要約】
本発明は、公知の活性物質ベンズチアズロン、メタベンズチアズロン、テブチウロン、イソプロツロン及び／またはエチオジン並びにその他の公知の活性物質の混合物を、建築用塗料、汚染防止塗料及び他の工業材料における藻類群生の抑制に使用する新規な方法に関する。
Patent NZ-197733-A (NZ)
Title: N-phenyl sulphonyl-n1-pyrimidinyl and triazinyl ureas
Inventor: MEYER WILLY
IPC: A01N47/36
Filed: 1981-07-16
Abstract: N-phenylsulphonyl-N'-diazinyl- and triazinyl-urea derivs. and their salts are new. A is 1-6C alkyl or 2-6C alkenyl, both opt. substd. by 1-4C alkoxy, 1-4C alkylthio, 1-4C alkylsulphinyl, 1-4C alkylsulphonyl 1-4C haloalkoxy, 1-4C haloalkylthio, 1-4C haloalkylsulphinyl or 1-4C haloalkylsulphonyl or A is 2-6C haloalkenyl. E is methine or N; X is O, S, sulphinyl or sulphonyl; Z is O or S- m is 1 or 2; R1 is H, halogen, 1-5C alkyl, 2-5C alkenyl, 1-4C haloalkyl, YR5, COOR6, NO2 or CONR7R8; R3 and R4 are each H, 1-4C alkyl, 1-4C alkoxy, 1-4C alkylthio, 1-4C haloalkyl, halogen or up to 4C alkoxyalkyl; R5 and R6 are each 1-5C alkyl, 2-5C alkenyl or 2-6C alkinyl; R7 and R8 are each H, 1-5C alkyl, 2-5C alkenyl or 2-6C alkinyl; Y is O, S, sulphinyl or sulphonyl. The intermediate phenylsulphonamide derivs. of formula (II) are also new. (a) R1, R2, A, M and X are as in (I) or (b) R1 and R2 are as in (I), but M=1, A=H and X is O or S. (I) are stable herbicides and plant growth regulators, which are easy to handle. (I) are highly selective and can be used e.g. in tropical areas to inhibit the growth of cover crops so they do not compete with the crops but without totally killing cover crops so that they still provide protection against soil erosion. (I) are esp. useful as selective herbicides in cereal, cotton, soya, maize and rice crops. -
Patent NZ-212241-A (NZ)
Title: Substituted pyrrolidinones and pharmaceutical compositions
Inventor: WEBER K-H
IPC: C07D413/12
Filed: 1985-05-29
Abstract: The invention relates to substituted pyrrolidinones of general formula    <IMAGE>  (1)  wherein R1 represents a phenyl group which may be mono- or di-substituted by methyl, methoxy, fluorine, chlorine, bromine or trifluoromethyl, or a pyridyl group; R2 represents hydrogen or a straight-chained or branched alkyl group with 1-4 carbon atoms; R3 represents a straight-chained or branched alkyl group with 1-3 carbon atoms, a hydroxyalkyl group with 2-3 carbon atoms, a phenyl group which can be mono- or di-substituted by chlorine, bromine, methyl or methoxy, a cyclohexyl group or a dialkylamino alkyl group, where in each alkyl group can contain from 1-3 carbon atoms; R4 represents hydrogen or a straight-chained or branched alkyl group with 1-3 carbon atoms; or R3 and R4 together with the nitrogen atom represent a piperidine, morpholine or piperazine ring, while the ring may be substituted by 1 or 2 methyl groups and the piperazine ring at the nitrogen atom in 4-position may also carry a phenyl, chlorophenyl or benzyl group, or they may represent the nortropanyl group, processes for preparing them and pharmaceutical compositions. The new compounds have proved effective in animal trials in alleviating or remedying conditions or restricted cerebral performance.
Patent NZ-223193-A (NZ)
Title: Tentering plastics sheet material between intermeshing grooved rollers
Inventor: RASMUSSEN OLE-BENDT
IPC: B29L9/00
Filed: 1988-01-14
Abstract: Sheet material 4 is stretched transversely into longitudinally extending pleats by passage between intermeshing grooved rollers A and B having circularly or helically extending grooves in their surfaces. Each groove is formed of a base 6a, 6b and side walls 5a, 5b inclined outwardly to a peak 7a, 7b. Portions of adjacent side walls 5a and 5b are parallel to one another. The peaks are less than about 3mm apart and the film is stretched by the peaks and is compressed between the side walls by forcing the rollers together. The pleated material is generally then stretched longitudinally substantially to eliminate the pleats and it may then be again stretched transversely between a further set of intermeshing grooved rollers.
Patent NZ-223566-A (NZ)
Title: Food extruder: trapped air removed
Inventor: TORAHIKO HAYASHI
IPC: F04C2/344
Filed: 1988-02-19
Abstract: Food material is introduced into a space (27) formed between the periphery of a drum (9) and the wall of a housing (7). The drum has an inner chamber (31) between its inner wall and the periphery of a cam (19). A pair of blades (15) is inserted into slits (13) formed on the drum so as to form a compartment on the outside of the drum and a compartment in the inner chamber (21). The dimensions of the outer compartment decrease towards the exit port (23), while those of the inner compartment increase, so a pressure differential is established and any air in the material is drawn into the inner chamber via a recess (17) on the trailing surface of the blade (15). Material of a uniform quantity and density, and that has no air entrainment, is thus extruded from the exit port.
Patent NZ-224215-A (NZ)
Title: Biocidal composition for water treatment comprising transition metal cations, quaternary ammonium biocide and a biocide containing a gem-halonitromethylene group
Inventor: STAINER PHILIP JOHN
IPC: C02F1/50
Filed: 1988-04-11
Abstract: A biocidal composition for the treatment of water comprises a cationic polyquaternary ammonium biocide, e.g. an ionene halide, or a quaternary ammonium biocide or a quaternary ammonium biocide comprising a long chain alkyl group and three other groups selected from lower alkyl and aralkyl groups, together with a source of transition metal cations e.g. copper II cations and/or a biocide of the type containing a gem. bromonitromethylene group e.g. 2- bromo-2-nitropropane-1,3-diol.
Patent NZ-237434-A (NZ)
Title: Antibodies and derivatives specific to the cd25 antigen, compositions containing them
Inventor: AMLOT PETER LLOYD
IPC: C07K16/00
Filed: 1991-03-14
Abstract: Novel monoclonal antibodies to the CD25 antigen are characterized by the amino acid sequence of their hypervariable regions. Initially produced in murine form, they may be converted to chimeric or humanized forms, immunoconjugates or antibody fragments (generally described as binding molecules). The products are useful for the prophylaxis or treatment of transplant rejection, paticularly in combination with other antibodies to activated T-cells, for example CD7 antibodies.
Patent NZ-237775-A (NZ)
Title: Private key telephone system emulates exchange signalling protocol
Inventor: OFFERS ALBERT GEORGE
IPC: H04Q3/58
Filed: 1991-04-10
Abstract: A key telephone system (120), having ports (22) for connection to telephone lines of a telephone exchange and ports (12) for connection of terminal apparatus including key telephone sets (125), is provided with the ability to distinguish if an intended call or feature access involves more than the key telephone system. If so, a signalling protocol of the telephone exchange is emulated on behalf of the terminal apparatus and transmitted via one of the telephone lines whereby the progress of the call or feature access continues, as if a user of the terminal apparatus had initiated the signalling protocol of the telephone exchange.
Patent NZ-243062-A (NZ)
Title: Aerosol containing medicament and 1,1,1,2-tetrafluoroethane
Inventor: FASSBERG JULIANNE
IPC: A61K31/58
Filed: 1992-06-08
Abstract: An aerosol formulation for administration of medicament has 1,1,1,2-tetrafluoroethane as propellant and an excipient which is a propylene glycol diester of a C₆-C₁₂ fatty acid or a triglyceride ester of a C₆-C₁₂ fatty acid.
Patent NZ-263620-A (NZ)
Title: The use of 4h-1-benzopyran-4-one derivatives as immunomodulators, cell adhesion inhibitors and agents for treating or preventing autoimmune diseases
Inventor: TANAKA KEIICHI
IPC: C07D311/22
Filed: 1994-04-07
Abstract: A 4H-1-benzopyran-4-one derivative of general formula Ä1Ü, or a salt thereof exerts excellent effects of immunomodulation and cell adhesion inhibition, and is further expected to have the effect of relieving autoimmune diseases at a level comparable to that of steroids. Thus the compound of general formula Ä1Ü is useful in the treatment and prevention of autoimmune diseases fundamentally caused by immunopathy or abnormally accelerated cell adhesion, for example, chronic rheumatoid arthritis, systemic lupus erythematosus, sclerema, mixed connective tissue disease, polyarteritis nodosa, polymyositis/dermatomyositis, Sjögren's syndrome, Behcet's disease, multiple sclerosis, autoimmune diabetes, Hashimoto's disease, psoriasis, primary myxedema, pernicious anemia, serious adynamia, ulcerative colitis, chronic active hepatitis, autoimmune hemolytic anemia and idiopathic thrombocytopenic purpura. <CHEM>
Patent NZ-307065-A (NZ)
Title: Polymers having polyethylenic backbone useful in packaging and adhesive applications and their use as oxygen scavengers in packaged products
Inventor: CHING TA YEN
IPC: B65D65/38
Filed: 1996-04-29
Abstract: Disclosed is a process for esterifying and/or transesterifying a polymer having a polyethylenic backbone and pendant acid and/or ester moieties comprising contacting a melt of the polymer with a transesterifying compound so that the polymer undergoes esterification and/or transesterification but not alcoholysis. The esterified or transesterified polymer also has pendant ester moieties that differ in kind and/or number from the unreacted polymer. In one embodiment, the process also comprises adding an amount of a transition metal salt that is effective to promote oxygen scavenging. Also in a further embodiment, the process comprises irridiating the transesterified polymer with actinic radiation to reduce the induction period before oxygen scavenging commences. Also disclosed are compositions comprising a component which comprises an ethylenic or polyethylenic backbone and a pendant or terminal moiety comprising a benzylic, allylic, or ether-containing radical. The invention also embodies new polyethylenic oxygen scavenging compositions comprising a transition-metal salt and the above component. Methods of making the compositions, and methods and compositions using the ethylenic or polyethylenic compositions, are disclosed.
Patent NZ-331713-A (NZ)
Title: Dual axle suspension with trailing arm supporting equaliser beam via saddle, and with air spring between chassis and trailing arm
Inventor: CADDEN ROBERT LESLIE
IPC: B60G9/02
Filed: 1998-09-03
Abstract: Disclosed is a suspension system 10 for installation between a chassis 14 and dual axles 18, 20 of a vehicle.  System 10 has an equaliser beam 22 pivotally linking the axles 18, 20 together.  A trailing arm support member 64 is pivotally attached to a hanger bracket 68 on chassis 14.  A suspension saddle 58 is secured to trailing arm support member 64 to provide pivotal support for equaliser beam 22 and air springs 72 located between chassis 14 and trailing arm support member.
Patent NZ-333445-A (NZ)
Title: Process for obtaining enantiomerically enriched N-acylazetidine-2-carboxylic acids comprising the biotransformation of racemic N-acylazetidine-2-carboxylic acid ester with an enantiospecific enzyme
Inventor: TAYLOR STEPHEN JOHN CLIFFORD
IPC: C12P41/00
Filed: 1997-07-15
Abstract: A process for obtaining an enantiomerically enriched N-acylazetidine-2-carboxylic acid, which process comprises the biotransformation of a racemic N-acylazetidine-2-carboxylic acid ester with an enzyme that displays enantiospecificity. The use of an enzyme displaying 1) properties characteristic of Candida antarctica lipase, Aspergillus tamarii esterase 2) enantiospecificity in the biotransformation of a racemic N-acylazetidine-2-carboxylic acid ester to an enantiomerically enriched N-acylazetidine-2-carboxylic acid is also disclosed.
Patent NZ-335605-A (NZ)
Title: Method of preventing corrosion of metal sheet using vinyl silanes
Inventor: VAN OOIJ WIM J
IPC: C09D4/00
Filed: 1997-11-04
Abstract: A method of preventing corrosion of a metal sheet, comprising the steps of: providing a metal sheet chosen from the group consisting of coated steel sheet, aluminum sheet and aluminum alloy sheet; and applying a solution containing at least one hydrolyzed vinyl silane to the metal sheet. A coating of paint or other polymer may be applied directly on top of the vinyl silane coating.
Patent NZ-502582-A (NZ)
Title: Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
Inventor: THORSETT EUGENE D
IPC: A61P25/28
Filed: 1998-07-30
Abstract: Compounds of formulae I and IA which bind VLA-4. Certain of these compounds also inhibit leukocyte adhesion and, in particular, leukocyte adhesion mediated by VLA-4. These compounds are useful in the treatment of inflammatory diseases such as asthma, Alzheimer's disease, atherosclerosis, AIDS dementia, diabetes, inflammatory bowel disease, rheumatoid arthritis, tissue transplantation, tumour metastasis and myocardial ischemia in a mammalian patient. The compounds are also useful for the treatment of inflammatory brain diseases such as multiple sclerosis. Reference has been directed, in pursuance of section 14 of the Patents Act 1953, to specification No. 502580.
Patent NZ-504044-A (NZ)
Title: A sanding tool which consists of sanding segments extending radially from a core in the formation of a cylindrical sanding tool
Inventor: HUNDEBOL KELD OTTING
IPC: B24D13/04
Filed: 1998-10-30
Abstract: A surface smoothing method using a multi-headed sanding tool.  The sanding tool comprises three cylindrical sanding tools (10), which rotate in one direction, indicated by arrow (8) and three cylindrical sanding tools (1), which rotate, in an opposite direction, indicated by arrow (9).  The six rotation axles (3) are housed in a drive (11) mounted on a turning shaft (12).  The sanding tools (10), which rotate in the rolling direction, are rotated slightly faster than the other sanding tools (1), rotating in the opposite direction, to maintain the same relative sanding speed.
Patent NZ-507152-A (NZ)
Title: Wall cladding assembly with cladding having recesses along opposite sides to engage with flanges of support members
Inventor: WOODBURY CHARLES HARRY
IPC: E04H5/10
Filed: 2000-09-27
Abstract: Longitudinally extending support members each have flanges which are received in respective recesses of wall panels.
Patent NZ-507946-A (NZ)
Title: Electrocapacitive type force measuring apparatus with a sensor unit for detecting a change in an electrostatic capacitance
Inventor: YAMAGATA YUTAKA
IPC: G01Q60/32
Filed: 2000-03-03
Abstract: An electrocapacitive force measuring apparatus comprising: a sensor unit (11) including a resiliently deforming portion (12) formed by a plat plate made of a hard material and having first and second end surfaces, said resiliently deforming portion being deformed in a bending fashion by an application of a force to be measured, a base portion (13) formed by a substantially U- shaped block made of hard material and having first and second end faces, said first end face being in parallel with the second end face, but being retarded from the second end face by a given gap distance, a first electrode provided on the first end surface of the resiliently deforming portion, a second electrode provided on the first end face of the base portion, a first electrode pad provided on the second end surface of the resiliently deforming portion, a second electrode pad provided on the second end face of the base portion, and a conductive pattern provided on the resiliently deforming portion such that the first electrode is electrically connected to the first electrode pad via said conductive pattern, whereby the resiliently deforming portion and base portion are coupled with each other at the first and second electrode pads; and a measuring circuit (21) having first and second input terminals connected to said second electrode and first electrode pad, respectively, and including an inductor which is connected to a capacitor formed by said first and second electrodes of the sensor unit in a serial or parallel manner to form a resonance circuit (22), the force applied to said resiliently deforming portion being measure as a change in a resonance frequency of said resonance circuit.